Kit ELISA PARC/CCL18 sandwich (human): quantitative determination of Hu PARC in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PARC.
Accession number
P55774
Dose range
2.74-2000 pg/ml
Sensitivity of the dosage
2 pg/ml
Calibration range
2 pg/ml to 400 folds
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA PARC/CCL18 sandwich (human): quantitative determination of Hu PARC in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PARC.
Kit ELISA PARC/CCL18 sandwich (human): quantitative determination of Hu PARC in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PARC.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The macrophage-4 inflammatory protein (MIP-4), also known as PARC or CCL18, is a chemokine expressed in lymph nodes, lungs, placenta and bone marrow. Although the MIP-4s receptor remains undetermined, MIP-4 is known to act as a chemotactic for activated and unactivated T cells.